Cell-cycle-gated feedback control mediates desensitization to interferon stimulation

Cells use sophisticated molecular circuits to interpret and respond to extracellular signal factors, such as hormones and cytokines, which are often released in a temporally varying fashion. In this study, we focus on type I interferon (IFN) signaling in human epithelial cells and combine microfluidics, time-lapse microscopy, and computational modeling to investigate how the IFN-responsive regulatory network operates in single cells to process repetitive IFN stimulation. We found that IFN-α pretreatments lead to opposite effects, priming versus desensitization, depending on the input durations. These effects are governed by a regulatory network composed of a fast-acting positive feedback loop and a delayed negative feedback loop, mediated by upregulation of ubiquitin-specific peptidase 18 (USP18). We further revealed that USP18 upregulation can only be initiated at the G1 and early S phases of cell cycle upon the treatment onset, resulting in heterogeneous and delayed induction kinetics in single cells. This cell cycle gating provides a temporal compartmentalization of feedback control processes, enabling duration-dependent desensitization to repetitive stimulations. Moreover, our results, highlighting the importance of IFN dynamics, may suggest time-based strategies for enhancing the effectiveness of IFN pretreatment in clinical applications against viruses, such as SARS-CoV-2.

[1]  R. Schwartz,et al.  Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.

[2]  Y. Yazdanpanah,et al.  Type 1 interferons as a potential treatment against COVID-19 , 2020, Antiviral Research.

[3]  Chengzhe Tian,et al.  Temporal integration of mitogen history in mother cells controls proliferation of daughter cells , 2020, Science.

[4]  Vineet D. Menachery,et al.  Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. , 2020, bioRxiv.

[5]  Vineet D. Menachery,et al.  Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV , 2020, Journal of Virology.

[6]  A. Hoffmann,et al.  Gene Regulatory Strategies that Decode the Duration of NFκB Dynamics Contribute to LPS- versus TNF-Specific Gene Expression. , 2020, Cell systems.

[7]  A. Sher,et al.  Visualizing the Selectivity and Dynamics of Interferon Signaling In Vivo. , 2019, Cell reports.

[8]  Abhyudai Singh,et al.  p53 pulse modulation differentially regulates target gene promoters to regulate cell fate decisions , 2019, Molecular systems biology.

[9]  Steven J. Altschuler,et al.  Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy , 2019, Cell.

[10]  Abdullahi Umar Ibrahim,et al.  Genome Engineering Using the CRISPR Cas9 System , 2019 .

[11]  Markus W. Covert,et al.  Techniques for Studying Decoding of Single Cell Dynamics , 2019, Front. Immunol..

[12]  V. Dötsch,et al.  Cell cycle arrest in mitosis promotes interferon-induced necroptosis , 2019, Cell Death & Differentiation.

[13]  K. Sakaguchi,et al.  Interferon stimulation creates chromatin marks and establishes transcriptional memory , 2018, Proceedings of the National Academy of Sciences.

[14]  E. Marder,et al.  Cellular function given parametric variation in the Hodgkin and Huxley model of excitability , 2018, Proceedings of the National Academy of Sciences.

[15]  Jia-Yun Chen,et al.  Fluctuations in p53 Signaling Allow Escape from Cell-Cycle Arrest. , 2019, Molecular cell.

[16]  Haidong Gao,et al.  USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway. , 2018, International journal of oncology.

[17]  S. Yao,et al.  The molecular basis of JAK/STAT inhibition by SOCS1 , 2018, Nature Communications.

[18]  Yuh Shiwa,et al.  iMETHYL: an integrative database of human DNA methylation, gene expression, and genomic variation , 2018, Human Genome Variation.

[19]  C. Scagnolari,et al.  Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome , 2018, Cytokine & Growth Factor Reviews.

[20]  Kevin Thurley,et al.  Modeling Cell-to-Cell Communication Networks Using Response-Time Distributions , 2018, Cell systems.

[21]  Viktória Hudacsek,et al.  [Genome engineering using the CRISPR-Cas9 system and applications in cancer research]. , 2018, Magyar onkologia.

[22]  M. Kimmel,et al.  Cell fate in antiviral response arises in the crosstalk of IRF, NF-κB and JAK/STAT pathways , 2018, Nature Communications.

[23]  G. Stark,et al.  Interferon-beta represses cancer stem cell properties in triple-negative breast cancer , 2017, Proceedings of the National Academy of Sciences.

[24]  N. Hao,et al.  Mitogen-activated protein kinase (MAPK) dynamics determine cell fate in the yeast mating response , 2017, The Journal of Biological Chemistry.

[25]  Jeff Hasty,et al.  Multigenerational silencing dynamics control cell aging , 2017, Proceedings of the National Academy of Sciences.

[26]  T. Meyer,et al.  Competing memories of mitogen and p53 signalling control cell-cycle entry , 2017, Nature.

[27]  B. Strauss,et al.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy , 2017, Oncotarget.

[28]  B. Strauss,et al.  Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy , 2017, Oncotarget.

[29]  L. Tsimring,et al.  Coupled feedback loops control the stimulus-dependent dynamics of the yeast transcription factor Msn2 , 2017, The Journal of Biological Chemistry.

[30]  G. Schreiber The molecular basis for differential type I interferon signaling , 2017, The Journal of Biological Chemistry.

[31]  Clifford A. Meyer,et al.  Transcriptional landscape of the human cell cycle , 2017, Proceedings of the National Academy of Sciences.

[32]  Ming Yan,et al.  STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling , 2017, Nature Structural &Molecular Biology.

[33]  T. Langan,et al.  Synchronization of Mammalian Cell Cultures by Serum Deprivation. , 2017, Methods in molecular biology.

[34]  Michael Z. Lin,et al.  Fluorescent indicators for simultaneous reporting of all four cell cycle phases , 2016, Nature Methods.

[35]  Omar P. Tabbaa,et al.  Dynamic control of gene regulatory logic by seemingly redundant transcription factors , 2016, eLife.

[36]  H. Herzel,et al.  Excitability in the p53 network mediates robust signaling with tunable activation thresholds in single cells , 2016, Scientific Reports.

[37]  M. Crow Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease? , 2016, Nature Reviews Rheumatology.

[38]  H. Decaluwe,et al.  Cytokines and persistent viral infections. , 2016, Cytokine.

[39]  G. Lahav,et al.  Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing , 2016, Cell.

[40]  Anatoly Kiyatkin,et al.  The Dark Side of Cell Signaling: Positive Roles for Negative Regulators , 2016, Cell.

[41]  W. Lim,et al.  Oscillatory stress stimulation uncovers an Achilles’ heel of the yeast MAPK signaling network , 2015, Science.

[42]  M. Ocker,et al.  Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study. , 2015, Oncology reports.

[43]  E. O’Shea,et al.  cis Determinants of Promoter Threshold and Activation Timescale. , 2015, Cell reports.

[44]  Sanjay Tyagi,et al.  Single-cell analysis shows that paracrine signaling by first responder cells shapes the interferon-β response to viral infection , 2015, Science Signaling.

[45]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[46]  P. Arimondo,et al.  Combined analysis of DNA methylation and cell cycle in cancer cells , 2015, Epigenetics.

[47]  V. Pascual,et al.  IFN Priming Is Necessary but Not Sufficient To Turn on a Migratory Dendritic Cell Program in Lupus Monocytes , 2014, The Journal of Immunology.

[48]  W. Średniawa,et al.  Dynamic JUNQ inclusion bodies are asymmetrically inherited in mammalian cell lines through the asymmetric partitioning of vimentin , 2014, Proceedings of the National Academy of Sciences.

[49]  M. De la Fuente,et al.  Chronic Inflammation and Cytokines in the Tumor Microenvironment , 2014, Journal of immunology research.

[50]  C. Rice,et al.  Interferon-stimulated genes: a complex web of host defenses. , 2014, Annual review of immunology.

[51]  R. Randall,et al.  Activation of the Interferon Induction Cascade by Influenza A Viruses Requires Viral RNA Synthesis and Nuclear Export , 2014, Journal of Virology.

[52]  Jared E. Toettcher,et al.  Using Optogenetics to Interrogate the Dynamic Control of Signal Transmission by the Ras/Erk Module , 2013, Cell.

[53]  Anders S Hansen,et al.  Promoter decoding of transcription factor dynamics involves a trade-off between noise and control of gene expression , 2013 .

[54]  David A. Scott,et al.  Genome engineering using the CRISPR-Cas9 system , 2013, Nature Protocols.

[55]  Javier A. Carrero Confounding roles for type I interferons during bacterial and viral pathogenesis , 2013, International immunology.

[56]  Sabrina L. Spencer,et al.  The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit , 2013, Cell.

[57]  C. Rice,et al.  IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage , 2013, The EMBO journal.

[58]  Wun-Jae Kim,et al.  Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[59]  G. Lahav,et al.  Encoding and Decoding Cellular Information through Signaling Dynamics , 2013, Cell.

[60]  Jeremy Gunawardena,et al.  Tunable Signal Processing Through Modular Control of Transcription Factor Translocation , 2013, Science.

[61]  K. Shuai,et al.  UBP 43 is a novel regulator of interferon signaling independent of its ISG 15 isopeptidase activity , 2013 .

[62]  K. Matsuura,et al.  Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene , 2012, Gut.

[63]  L. Tsimring,et al.  Vacuum-assisted cell loading enables shear-free mammalian microfluidic culture. , 2012, Lab on a chip.

[64]  J. Kirkwood,et al.  IFN-α in the Treatment of Melanoma , 2012, The Journal of Immunology.

[65]  Jeremy E. Purvis,et al.  p53 Dynamics Control Cell Fate , 2012, Science.

[66]  Thomas Höfer,et al.  Multi-layered stochasticity and paracrine signal propagation shape the type-I interferon response , 2012, Molecular systems biology.

[67]  Erin K O'Shea,et al.  Signal-dependent dynamics of transcription factor translocation controls gene expression , 2011, Nature Structural &Molecular Biology.

[68]  D. Choubey,et al.  Interferons in autoimmune and inflammatory diseases: regulation and roles. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[69]  C. Rice,et al.  Interferon-stimulated genes and their antiviral effector functions , 2011, Current Opinion in Virology.

[70]  S. Pellegrini,et al.  USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response , 2011, PloS one.

[71]  Galit Lahav,et al.  Stimulus-dependent dynamics of p53 in single cells , 2011, Molecular systems biology.

[72]  A. Yoshimura,et al.  Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[73]  D. Tough,et al.  Interferon‐β and interferon‐λ signaling is not affected by interferon‐induced refractoriness to interferon‐α in vivo , 2011, Hepatology.

[74]  M. Heim,et al.  44 INTERFERON-β AND -λ SIGNALING IS NOT AFFECTED BY INTERFERON-INDUCED REFRACTORINESS TO INTERFERON-α IN VIVO , 2011 .

[75]  T. Langan,et al.  Synchronization of mammalian cell cultures by serum deprivation. , 2011, Methods in molecular biology.

[76]  Alexander Hoffmann,et al.  Understanding the temporal codes of intra-cellular signals. , 2010, Current opinion in genetics & development.

[77]  Timothy K Lee,et al.  Single-cell NF-κB dynamics reveal digital activation and analogue information processing , 2010, Nature.

[78]  Alan S. Perelson,et al.  Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus , 2010, Journal of Virology.

[79]  L. Tsimring,et al.  A synchronized quorum of genetic clocks , 2009, Nature.

[80]  Zhenghong Yuan,et al.  Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. , 2009, The Journal of general virology.

[81]  K. Zoon,et al.  IRF9 is a Key Factor for Eliciting the Antiproliferative Activity of IFN-α , 2009, Journal of immunotherapy.

[82]  Ming Yan,et al.  Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43 , 2009, Molecular and Cellular Biology.

[83]  D. S. Broomhead,et al.  Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription , 2009, Science.

[84]  Dong-er Zhang,et al.  The Level of Hepatitis B Virus Replication Is Not Affected by Protein ISG15 Modification but Is Reduced by Inhibition of UBP43 (USP18) Expression1 , 2008, The Journal of Immunology.

[85]  S. Sealfon,et al.  Interferon-β Pretreatment of Conventional and Plasmacytoid Human Dendritic Cells Enhances Their Activation by Influenza Virus , 2008, PLoS pathogens.

[86]  K. Keyomarsi,et al.  Synchronization of the cell cycle using Lovastatin , 2008, Cell cycle.

[87]  Megan N. McClean,et al.  Signal processing by the HOG MAP kinase pathway , 2008, Proceedings of the National Academy of Sciences.

[88]  Jerome T. Mettetal,et al.  The Frequency Dependence of Osmo-Adaptation in Saccharomyces cerevisiae , 2008, Science.

[89]  Ali Danesh,et al.  Human immunopathogenesis of severe acute respiratory syndrome (SARS) , 2007, Virus Research.

[90]  Ming Yan,et al.  Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. , 2007, Biochemical and biophysical research communications.

[91]  M. Fraga,et al.  Variations in DNA Methylation Patterns During the Cell Cycle of HeLa Cells , 2007, Epigenetics.

[92]  K. Shuai,et al.  UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.

[93]  Gürol M. Süel,et al.  An excitable gene regulatory circuit induces transient cellular differentiation , 2006, Nature.

[94]  R. Momparler Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine). , 2005, Seminars in oncology.

[95]  D. Baltimore,et al.  Achieving Stability of Lipopolysaccharide-Induced NF-κB Activation , 2005, Science.

[96]  G. Cheng,et al.  The host type I interferon response to viral and bacterial infections , 2005, Cell Research.

[97]  L. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[98]  T. Whiteside,et al.  Alpha-interferon , 1989, Digestive Diseases and Sciences.

[99]  gangChen,et al.  The host type I interferon response to viral and bacterial infections , 2005 .

[100]  David Baltimore,et al.  Achieving stability of lipopolysaccharide-induced NF-kappaB activation. , 2005, Science.

[101]  Ming Yan,et al.  Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection , 2004, Nature Medicine.

[102]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[103]  D B Kell,et al.  Oscillations in NF-kappaB signaling control the dynamics of gene expression. , 2004, Science.

[104]  S. Mangan,et al.  The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. , 2003, Journal of molecular biology.

[105]  D. Lavelle,et al.  Decitabine induces cell cycle arrest at the G1 phase via p21(WAF1) and the G2/M phase via the p38 MAP kinase pathway. , 2003, Leukemia research.

[106]  Ming Yan,et al.  Protein ISGylation modulates the JAK-STAT signaling pathway. , 2003, Genes & development.

[107]  A. Hoffmann,et al.  The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .

[108]  Takeshi Norimatsu,et al.  Encoding and Decoding , 2016 .

[109]  J. Christman,et al.  5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy , 2002, Oncogene.

[110]  S. Shen-Orr,et al.  Network motifs in the transcriptional regulation network of Escherichia coli , 2002, Nature Genetics.

[111]  A. Hoffmann,et al.  The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. , 2002, Science.

[112]  G. Barber Host defense, viruses and apoptosis , 2001, Cell Death and Differentiation.

[113]  G. Petsko The dark side , 2000, Genome Biology.

[114]  P. Branton,et al.  Viruses and apoptosis. , 1999, Annual review of microbiology.

[115]  K. Keyomarsi,et al.  Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. , 1991, Cancer research.

[116]  A. Morley,et al.  Delayed DNA methylation is an integral feature of DNA replication in mammalian cells. , 1986, Experimental cell research.

[117]  W. Stewart,et al.  Interferon priming. Effects on interferon messenger RNA. , 1979, The Journal of biological chemistry.

[118]  K. Smith What is a Virus? , 1955, Nature.